Innate Pharma (the Company - Euronext Paris: FR0010331421 – IPH) announces today the signature of a liquidity agreement with NatIxis Securities. The agreement will be effective September 21, 2009, for a period of one year with tacit renewal.
Innate Pharma has allocated 300,000 euros (three hundred thousands) to this contract.
| PR in english | 31.66 KB |
| CP en français | 30.88 KB |